Pages qui pointent vers « A phase three review of bevacizumab plus erlotinib and gemcitabine in sufferers with metastatic pancreatic adenocarcinoma didn't demonstrate an increase in all round survival »
De Les Feux de l'Amour - Le site Wik'Y&R du projet Y&R.